This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lee, J. M. Articles by Choudhury, R. P Search for Related Content Social Bookmarking                         What's this?

ARBITER 2: targeting HDL to retard atherosclerosis progression

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2

Robin P Choudhury

Department of Cardiovascular Medicine, Level 5, John Radcliffe Hospital, Headington, Oxford, OX3 9DU, UK, robin.choudhury{at}cardiov.ox.ac.uk

Key Words: statins • niacin • cholesterol.

References

• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Cannon CP, Braunwald CE, McCabe CH et al., the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. N Engl J Med 2004;350:1495-504.[Abstract/Free Full Text]
• Pasternak RC, Smith SC, Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C., Writing Committee Members:. ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. Circulation 2002;106:1024-8.[Free Full Text]
• Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S., Kannel WB Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986;256:2835-8.[Abstract/Free Full Text]
• Gordon T., Castelli WP, Hjortland MC, Kannel WB, Dawber TR High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977;62:707-14.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Rubins HB, Robins SJ, Collins D. et al., The Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol. N Engl J Med 1999;341:410-18.[Abstract/Free Full Text]
• Piepho RW The pharmacokinetics and pharmacodynamics of agents proven to raise high-density lipoprotein cholesterol. Am J Cardiol 2000;86:35L-40L.[Web of Science][Medline] [Order article via Infotrieve]
• Canner PL, Berge KG, Wenger NK et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986;8:1245-55.[Abstract]
• Taylor AJ, Sullenberger LE, Lee HJ, Lee JK, Grace KA Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: A Double-Blind, Placebo-Controlled Study of Extended-Release Niacin on Atherosclerosis Progression in Secondary Prevention Patients Treated With Statins. Circulation 2004;110:3512-17.[Abstract/Free Full Text]
• Morgan JM, Capuzzi DM, Guyton JR A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients. Am J Cardiol 1998;82:29U-34U; discussion 39U-41U.[CrossRef][Web of Science]
• Assmann G., Schulte H., von Eckardstein A., Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996;124(suppl):S11-S20.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Rubins HB, Robins SJ, Collins D. et al. Distribution of Lipids in 8,500 Men With Coronary Artery Disease. Am J Cardiology 1995;75:1196-201.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Girman CJ, Rhodes T., Mercuri M. et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 2004;93:136-41.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.[Free Full Text]
• Chapman MJ, Assmann G., Fruchart JC, Shepherd J., Sirtori C. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid - a position paper developed by the European Consensus Panel on HDL-C. Curr Med Res Opin 2004;20:1253-68.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis MN ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: A Randomized Trial Comparing the Effects of Atorvastatin and Pravastatin on Carotid Intima Medial Thickness. Circulation 2002;106:2055-60.[Abstract/Free Full Text]
• Corti R., Fuster V., Fayad ZA et al. Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions: Two Years' Follow-Up by High-Resolution Noninvasive Magnetic Resonance Imaging. Circulation High-Resolution Noninvasive Magnetic Resonance Imaging. Circulation 2002;106:2884-7.[Abstract/Free Full Text]
• Coronary Drug Project report on clofibrate and niacin. Atherosclerosis 1978;30:239-40.[CrossRef][Medline] [Order article via Infotrieve]
• Reaven P., Witztum JL Lovastatin, nicotinic acid, and rhabdomyolysis. Ann Intern Med 1988;109:597-8.[Abstract/Free Full Text]
• Kashyap ML, McGovern ME, Berra K. et al. Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia. Am J Cardiol 2002;89:672-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Tunaru S., Kero J., Schaub A. et al. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 2003;9:352-5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Jin F-Y., Kamanna VS, Kashyap ML Niacin Decreases Removal of High-Density Lipoprotein Apolipoprotein A-I But Not Cholesterol Ester by Hep G2 Cells: Implication for Reverse Cholesterol Transport. Arterioscler Thromb Vasc Biol 1997;17:2020-8.[Abstract/Free Full Text]
• Rubic T., Trottmann M., Lorenz RL Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin. Biochem Pharmacol 2004;67:411-19.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Burke GL, Evans GW, Riley WA et al. Arterial Wall Thickness Is Associated With Prevalent Cardiovascular Disease in Middle-Aged Adults: The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 1995;26:386-91.[Abstract/Free Full Text]
• O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, The Cardiovascular Health Study Collaborative Research Group. Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults. N Engl J Med 1999;340:14-22. 27. Choudhury RP, Rong JX, Trogan E. et al. High-Density Lipoproteins Retard the Progression of Atherosclerosis and Favorably Remodel Lesions Without Suppressing Indices of Inflammation or Oxidation. Arterioscler Thromb Vasc Biol 2004;24:1904-09.[Abstract/Free Full Text]

The British Journal of Diabetes & Vascular Disease, Vol. 5, No. 2, 78-80 (2005)
DOI: 10.1177/14746514050050020501


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lee, J. M. Articles by Choudhury, R. P Search for Related Content Social Bookmarking                         What's this?